Clinical Outcomes of Critically Ill Patients Using Inhaled Nitric Oxide (iNO) during Intrahospital Transport
Table 2
iNO treatment data and intrahospital patient transportation (Group (2)) data during the ICU stay.
Group 1 (n = 156)
Group 2 (n = 65)
value
Maximal iNO dosage during ICU stay (ppm, mean ± SD)
35.08 ± 15.618
40.95 ± 18.488
0.017
iNO dosage during intrahospital transportation (ppm, mean ± SD)
NA
32.51 ± 14.181
—
iNO treatment length (days, mean ± SD)
4.5 ± 4.643
9.57 ± 10.239
0.0001
Duration of intrahospital transportation (minutes, mean ± SD)
NA
116.89 ± 10.7
—
Intrahospital transport location (%)
CTa
NA
52.2%
—
Operating room (OR)
NA
41.8%
—
Other (angiography, other intensive care unit)
NA
6%
—
Frequency of intrahospital transportation (%)
One
NA
71.6%
—
Two
NA
14.9%
—
Three
NA
4.5%
—
Group 1: critically ill patients who were not transported outside of the ICU during their hospitalization period. Group 2: critically ill patients who were transported outside of the ICU during iNO treatment during their hospitalization period. Data are considered statistically significant if .aCT: computerized tomography.
